Streck, Inc., a medical device manufacturing company is the technology leader in the stabilization of cells.

Core products are hematology and flow cytometry controls and reagents. After introducing the first three and five-part differential controls, the company developed the first reticulocyte control and offers patent-protected five-part differential controls plus reticulocytes and nucleated red blood cells. Other Streck products include automated Erythrocyte Sedimentation Rate analyzers, point of care chemistry controls and unique quality control devices.

www.streck.com